Revenue Related Information

6 Months Ended

Jun. 30, 2022

Revenue Related Information

Revenue Related Information

4.Revenue Related Information

The Company’s revenue is primarily consisted of sales of EVOMELA ^®. As of June 30, 2022, the Company did not incur, and therefore did not defer, any material costs to obtain or fulfill contracts. The Company did not have any contract assets or contract liabilities as of June 30, 2022 and December 31, 2021. There was no product exchange during the periods ended June 30, 2022 and 2021.